Once the underlying rationale of the test is understood, steps can be taken to either augment the psychophysiological response to control questions (eg via self-induced physical or mental pain) or else reduce the response to relevant questions (eg using mental training, such as meditation).
The underlying biological rationale of the test is that disturbance of neural crest migration by toxicants leads to severe malformations in different species.
This, according to the rationale of the test, revealed that a selection against nonsynonymous mutations is working in M. senhousia, i.e. purifying selection is occurring within M and F sequences.
The rationale of this test is the following: Under the null hypothesis, the individual covariance values at a given electrode are expected to have a distribution with zero mean.
The observation that cancer cells harbouring CCNE1 gene amplification are sensitive to CDK2 inhibitors provides a rationale for the testing of these chemical inhibitors in a subgroup of patients with ER-negative grade III breast cancers.
Despite a sound scientific rationale for the testing of HDAC inhibitors, only a single weak inhibitor, VPA, has been tested, and only in a handful of patients.
Together, these studies provide a rationale for the testing of PI3K pathway inhibitors in HPV+ HNSCC.
These findings provide a strong rationale for the testing of combined BRAF and MEK inhibitors in the clinical setting.
In summary, our results provide rationale for the testing of combined EGFR and mTOR inhibitors, at least in the subset of RCC patients with wt-VHL.
The basic rationale of the Dm test is that natural selection can influence the frequency spectrum of DNA methylation polymorphism, which could be detected by the difference of and.
